Real World Best Practices for DVT Prophylaxis

	Faculty
		Paul E. Marik, MD, FCCP, FCCM Professor of Medicine Director, Pulmonary and Critical Care Medicine Thomas Jefferson University Dr. Marik received his medical degree from the University of the Witwatersrand, Johannesburg, South Africa. He did his internship at Hillbrow Hospital and then completed his medical residency at Johannesburg Hospital, Johannesburg, South Africa. He was an attending at Baragwanath Hospital, in Soweto, South Africa. During this time he obtained a Master of Medicine Degree, Bachelor of Science Degree in Pharmacology, Diploma in Anesthesia as well as a Diploma in Tropical Medicine and Hygiene. Dr. Marik did a Critical Care Fellowship in London, Ontario, Canada, during which time he was admitted as a Fellow to the Royal College of Physicians and Surgeon of Canada. Dr. Marik is currently Professor of Medicine and Chief of Pulmonary and Critical Care Medicine, Thomas Jefferson University in Philadelphia. Dr. Marik has written over 200 peer reviewed journal articles, 30 book chapters and authored two critical care hand-books. He has presented over 160 lectures at National and International Meetings and Invited Grand Rounds.
		Arthur P. Wheeler, MD, FCCP Associate Professor Division of Allergy, Pulmonary and Critical Care Medicine Vanderbilt University, School of Medicine Director, Medical Intensive Care Unit Dr. Wheeler is an Associate Professor in the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University. He is a graduate of the University of Maryland School of Medicine then completed training programs in Internal Medicine, Pulmonary Disease and Critical Care at Vanderbilt University. He is a member of the American Thoracic Society, Society of Critical Care Medicine, and American Federation for Clinical Research and is a Fellow of the American College of Chest Physicians. His research in sepsis, thromboembolic disease, and acute lung injury has resulted in more than 100 publications. He is the co-author of a successful textbook of Critical Care Medicine now in its third edition. Dr. Wheeler has delivered hundreds of National and International lectures and is the recipient of numerous teaching awards. He currently serves as the Director of the Vanderbilt ICU.
		Jamie E. Siegel, MD Clinical Associate Professor of Medicine Cardeza Foundation for Hematologic Research Director, Hemophilia and Thrombosis Center Thomas Jefferson University Hospital Medical Director, Cardeza Foundation Special Hemostasis Laboratory Dr. Jamie E. Siegel is Clinical Associate Professor of Medicine at Cardeza Foundation for Hematologic Research and the Division of Hematology, Director of the Hemophilia and Thrombosis Center at Thomas Jefferson University Hospital in Philadelphia as well as Medical Director of the Cardeza Foundation Special Hemostasis Laboratory. Dr. Siegel received her undergraduate degree from Lehigh University in the Medical College of Pennsylvania joint BA-MD program. She went on to attend the Medical College of Pennsylvania in Philadelphia, PA were she also completed her internal medicine residency and fellowship in Hematology/Oncology. She did an additional year as a Cardeza Clinical and Research Fellow in Hematology at Thomas Jefferson University. Dr. Siegel became a National Boards Diplomate over 20 years ago and subsequently Diplomate in Internal Medicine, Diplomate in Medical Oncology, and Diplomate in Medical Hematology. Her memberships in professional organizations include International Society on Thrombosis and Hemostasis, American Society of Hematology, American College of Physicians, and American Society of Clinical Pathologists. She has served on the boards of the Hemophilia Foundation, Delaware Valley and Hemophilia Association of New Jersey, and is the Co-director of the Medical Advisory Board for Hemophilia Federation of America. Publications, studies and lectures by Dr. Siegel have addressed laboratory monitoring of heparin, heparin thrombocytopenia, as well as various bleeding disorders including von Willebrand Disease and Hemophilia. Her concentration in this work has gained her national recognition. Dr. Siegel has also received the Humanitarian Award from the Hemophilia Association of New Jersey, the Ron Niederman Humanitarian Award from the Hemophilia Federation of America and the Gender Equity Award from MCP/MCPHU Student AMWA Chapter.
		Sandra L. Kane-Gill, PharmD, MSc Assistant Professor Pharmacy and Therapeutics University of Pittsburgh Sandra L. Kane-Gill, PharmD, MSc received her baccalaureate pharmacy degree from Wayne State University in 1994. She completed an ASHP accredited pharmacy practice residency at West Virginia University Hospital in 1996. In 1998 she received her Doctorate of Pharmacy from the University of Toledo. Dr. Kane-Gill then pursued her Masters of Science in Pharmacy Administration with emphasis on Pharmacoeconomics and Health Outcomes at the Ohio State University in Columbus, Ohio from 1999-2001. Between 1998-2001 she completed her Critical Care Fellowship at the Ohio State University. Upon completion of her training she joined the faculty of the University of Pittsburgh, School of Pharmacy in 2001 with an appointment as Assistant Professor in the Department of Pharmacy and Therapeutics for the Center for Pharmacoinformatics and Outcomes Research. Dr. Kane-Gill’s research interests focus on economic, clinical and humanistic evaluations for critically ill patients; specifically patient safety, quality of life in patients receiving sedatives/neuromuscular blockers, and developing models of cost for acute illness. She has served as Principal Investigator and Co-Investigator on several funded research grants in this area of study. Her research projects spanned the areas of anticoagulation, infectious disease, antidysrhythmics, sedation and adverse drug events. Her work has been presented as both oral and poster presentations at several national and international professional meetings including the Society of Critical Care Medicine (SCCM), European Society of Intensive Care Medicine, Annual American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), as well as local professional meetings. She has published over 30 abstracts and 20 peer-reviewed manuscripts. Dr. Kane-Gill is very involved in national and international organizations through active membership in ACCP, SCCM, ASHP, International Society for Pharmacoeconomics and Outcomes Research. Currently she holds the appointment of past-chair for the Clinical Pharmacy and Pharmacology Section of SCCM. Also, she has recently been elected as a member of the United States Pharmacopeia Therapeutic Decision Making Expert Committee.
	*Disclosure Policy* It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators. Faculty Disclosure Declarations Paul E. Marik, MD, FCCP, FCCM– Nothing to disclose Arthur P. Wheeler, MD, FCCP– Consultant/Speakers Bureau – Sanofi-Aventis Jamie E. Siegel, MD– Nothing to disclose Sandra L. Kane-Gill, PharmD., MSc.– Nothing to disclose Printer settings may vary. Please use landscape layout option. Copyright © 2006 ArcMesa Educators / CMEdiscovery.com. All rights reserved. .